Asia Fresh News

Asia Fresh Stories

Archive for April 28th, 2015

Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV)

leave a comment »

— Results Presented at European Association for the Study of the Liver (EASL) Meeting in Vienna, Austria

PALO ALTO, Calif., April 27, 2015 /PRNewswire/ — Eiger BioPharmaceuticals, Incorporated today announced the presentation of interim results of Phase 2 data of lonafarnib in patients with chronic hepatitis delta viral (HDV) infection. Data were presented from the LOWR HDV program, enrolled at Ankara University Medical School, Turkey, in a country where HDV is endemic.

Logo – http://photos.prnewswire.com/prnh/20141221/165715LOGO

LOWR HDV – 1 (LOnafarnib With and without Ritonavir-1) is a parallel dose comparison study which randomized subjects to receive different doses of lonafarnib with or without ritonavir or pegylated interferon for four to twelve weeks. Interim data from 15 subjects who received lonafarnib alone or with ritonavir boosting or in combination with pegylated interferon all led to decreased viral loads. High doses (200 mg twice daily or 300 mg twice daily) of lonafarnib resulted in 1.6 and 2.0 log decline in viral loads after 4 weeks of treatment, respectively. A lower dose of lonafarnib (100 mg twice daily) with 100 mg daily ritonavir boosting or in combination with 180 mcg once weekly of pegylated interferon resulted in a 2.2 and a 1.8 log decline in viral load at week 4, respectively. At week 8, the mean viral load declines were 3.2 and 3.0 logs for subjects on lonafarnib with ritonavir or lonafarnib with pegylated interferon, respectively.

The most frequently observed adverse events in LOWR-1 were anorexia, nausea, diarrhea, fatigue, and weight loss, and these appeared to be dose-dependent.

LOWR HDV – 2 (LOnafarnib With Ritonavir-2) was recently initiated to test a range of doses of lonafarnib boosted by ritonavir, with the aim to identify optimal combination(s) for the next longer-term studies.

“The data generated thus far investigating lonafarnib combinations are very encouraging,” said Cihan Yurdaydin, MD, Principal Investigator, Ankara University Medical School. “We continue to conduct dose finding with lonafarnib boosted by ritonavir to identify the optimal balance of efficacy and tolerability, with a goal of viral clearance.”

About Lonafarnib
Lonafarnib is a well-characterized, late stage, orally active agent targeting farnesyltransferase, an enzyme involved in modification of proteins through a process called prenylation. HDV uses this host cellular process inside liver cells to complete a key step in its life cycle. Lonafarnib inhibits the prenylation step of HDV replication inside liver cells and blocks the virus life cycle at the stage of assembly. Since prenylation is carried out by a host enzyme there is a theoretical higher barrier to develop viral resistance mutations to lonafarnib therapy.

Lonafarnib has been granted Orphan Drug Designation by the US FDA and the European Medicines Agency (EMA), and Fast Track designation by US FDA. Lonafarnib is an investigational product and its safety and efficacy have not yet been established for any indication. Lonafarnib is licensed from Merck Sharp & Dohme Corp. (known as MSD outside the United States and Canada).

About HDV
Hepatitis Delta is caused by infection with the hepatitis D virus (HDV) and is considered to be the most severe form of viral hepatitis in humans. Hepatitis D occurs only as a co-infection in individuals harboring hepatitis B virus (HBV). Hepatitis D leads to more severe liver disease than HBV alone, and is associated with accelerated liver fibrosis, liver cancer, and liver failure. Hepatitis D is a disease with a significant impact on global health affecting ~15 million people worldwide. The prevalence of HDV varies between different parts of the world. Globally, HDV infection is reported to be 5-6% of chronic hepatitis B carriers. In some parts of the world, including certain areas of China, Mongolia, Russia, Central Asia, Turkey, Africa, and South America, HDV prevalence as high as 70% has been reported in HBV infected patients.

About Eiger
Eiger is a privately held biotechnology company focused on the research, development and commercialization of innovative therapies in viral hepatitis. The company is focused on developing lonafarnib for the treatment of Hepatitis Delta Virus (HDV), the most severe form of viral hepatitis. For additional information about Eiger and its R&D pipeline, please visit http://www.eigerbio.com.

Investors: Jim Shaffer, Eiger BioPharmaceuticals, Inc., 919-345-4256, jshaffer@eigerbio.com
Source: Eiger BioPharmaceuticals, Inc.

Written by asiafreshnews

April 28, 2015 at 11:13 pm

Posted in Uncategorized

SYSPRO Software Wins Gold Stevie(R) Award in 2015 Asia-Pacific Stevie Awards

leave a comment »

HONG KONG  /PRNewswire/ — SYSPRO Software was named the winner of a Gold Stevie® Award in the Supply Chain Management Solution category at the second annual Asia-Pacific Stevie Awards today.

The Asia-Pacific Stevie Awards are the only business awards program to recognize achievement in the workplace in all 22 nations of the Asia-Pacific region. The Stevie Awards are widely considered to be the world’s premier business awards, conferring recognition for achievement in programs such as The International Business Awards for more than a decade.

More than 400 nominations from organizations across the Asia-Pacific region were considered this year in categories such as Company of the Year, Executive of the Year, and Website of the Year. SYSPRO Software won in the Supply Chain Management Solution category.

Shaun Butler, SYSPRO CEO for the Asia Pacific region said; “This award belongs to everybody at SYSPRO Software that has worked with great diligence and commitment to understand the needs and expectations of ourAsia Pacific customers. Managing highly complex projects and supply demands, whilst maintaining technical performance were fundamental to meeting those expectations.” He continued; “I would also like to congratulate the other businesses who have won Stevie awards in 2015.”

Gold, Silver and Bronze Stevie Award winners were selected by more than 50 executives around the world who participated in first-round judging in March and April. A second international panel of judges will choose Grand Stevie winners from among the Gold winners in May. The Grand Stevie winners will be announced at the 5 June banquet in Shanghai.

About SYSPRO Software

Established in 1978, SYSPRO delivers both on-premises and cloud-based business software to customers in over 60 countries. SYSPRO and its network of solution providers have earned the trust of companies across a variety of industry sectors by creating enterprise resource planning (ERP) software and services that combine simplicity of use with rich information visibility and business processes.

About the Stevie® Awards
Stevie Awards are conferred in six programs: the Asia-Pacific Stevie Awards, Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at www.StevieAwards.com.

Contact:

Jo Burnett
Phone Number: +61-2-9870-5555
Email: info@au.syspro.com

Source: SYSPRO Software Pty Ltd

Written by asiafreshnews

April 28, 2015 at 6:18 pm

Posted in Uncategorized

Movideo Announces Two New Director Roles to Further Expand Its Global Leadership Team

leave a comment »

-Ashok Seshadri has been appointed Director of Product and Yogaesh Ramasundaram as Director of Engineering

MELBOURNE, Australia /PRNewswire/ — Movideo has today announced two new Director roles to its expanding Global Leadership Team.

As Director of Product, Ashok Seshadri will be based out of the companies head office in Melbourne and will be responsible for the roadmap of the Movideo Platform and Movideo HUB.

Ashok has been in the technology arena for more than 14 years having worked for Intel, Samsung, and Ooyala.  He joins the Movideo team from Ooyala where he was the product lead on the platform side of the business managing the API stack, asset management system (DAM), data model and workflow engine.  Most recently his efforts involved launching a next gen best of breed SOA based video platform including a state of the art DAM and media specific workflow engine. During his career he has held roles including those of design engineer, marketing manager, and has been involved heavily in roadmap and strategy management, and product management. He graduated from Georgia Institute of Technology at Atlanta, GA with a major in Computer Engineering and holds an MBA from Santa Clara University in Finance and International Business.

Yogaesh Ramasundaram will join the Movideo team as Director of Engineering, the second of the two newly created roles also based in the Melbourne headquarters. As Director of Engineering, Ramasundaram will be responsible for the platforms architecture including continually optimizing products, solutions, quality and performance.

Yogaesh Ramasundaram offers 11 years of accomplishment laden experience in the IT industry, having been a part of the engineering leadership team at Ooyala and Samsung Music, Yogaesh brings valuable insight and knowledge about the media space. Most recently, he was a strategic and tactical contributor for the video platform team at Ooyala, managing core platform teams responsible for delivering Yaveo, the Hispanic OTT program from DirecTV and the nextgen, SOA based, SaaS video platform. Beginning his career in the Information Management industry as a Java programmer, Yogaesh quickly grew into a Project Leader and then a manager, gaining experience on multiple technologies, domains, CMMi Level 5 delivery processes and Agile methodologies. Focusing the next several years on Architecture and Engineering leadership, Yogaesh was a part of the Engineering leadership team and the head of the Open Source Practice, at a Seattle based startup. Yogaesh has a Master’s Degree in Software Engineering Birla Institute of Technology and Science, Pilani and a Bachelor’s Degree in Computer Science and Engineering Thiagarajar College of Engineering.

Commenting on the new leadership roles, Tony McGinn, CEO said, “We are thrilled to expand our team with talent that have such deep and relevant experience. As a global media-centric SaaS business with our core development resources in Australia, Ashok and Yogaesh are outstanding additions to our awesome multinational development team in Melbourne, straight from the heart of Silicon Valley. Their leadership skills, technical depth and vision will be experienced very soon by our media customers with the rapid development and enhancement of our products and services.”

It has been a year of big announcements and structural development for Movideo thus far, this announcement follows the appointment of Steven Kopec from Turner Broadcasting Inc. as Director of Customer Success in March. Also France’s TV 5 MONDE announced it was the latest media group to join Disney, Turner, Astro, Samsung, Nextmedia, BHD and SPH on the global Movideo platform solution for OTT.

For more information, contact Movideo:

Claire Moylan
Marketing Executive
Phone: +61-3-96356696
cmoylan@movideo.com
@MovideoMVP

About Movideo:

Movideo has fast become the agile partner of choice for major media brands and content owners around the world. With considerable experience across one of the most complex regions in the world, the Asia Pacific, Movideo has a track record of simplifying complex multi-local solutions, as opposed to a ‘one size fits all’ approach.

Movideo is a global SaaS cloud video platform resourced by the international Microsoft Azure network of data centres. The company was originally developed within the Australian media enterprise, MCM Entertainment Group Ltd. Media content protection, management, distribution, presentation and monetisation is core to Movideo’s DNA.

With the media and content world in the midst of massive structural change, Movideo prides itself on partnering with our media customers to navigate and ‘future proof’ their path to successful audience engagement in the new media world order.

Source: Movideo
Related Links:

Written by asiafreshnews

April 28, 2015 at 6:11 pm

Posted in Uncategorized

MecklerMedia to Launch ‘Inside 3D Printing Conference & Expo’, the Asia’s Largest 3D Printing Tradeshow on June 24-26, 2015 in Seoul

leave a comment »

SEOUL, South Korea  /PRNewswire/ — MecklerMedia and KINTEX (Korea International Exhibition Center) announced that Inside 3D Printing Conference & Expo 2015  Seoulwill mark its 2nd grand opening at KINTEX, South Korea on June 24th.  This Must-Visit trade show and conference will go on for 3 days and drop the curtain on June 26th.

Inside 3D Printing Seoul is the most vibrant trade show in 3D printing industry
Inside 3D Printing Seoul is the most vibrant trade show in 3D printing industry

The Seoul event, undisputedly the largest in Korea and one of the most noticeable and state-of-the-art 3D Printing tradeshows in Asian region, will be more exciting and vibrant than ever before with soaring popularity of brand-new AM(Additive Manufacturing) technologies applicable to various fields throughout the whole globe.

Looking inside the Inside 3D Printing Conference & Expo 2015 – Seoul will deliver you the pure pleasure of exploring all 3D Printing secrets of global village from rapid prototyping, fashion designs to surgical implants. More than 100 local/oversea companies with approximately 150 booths are ready to welcome and excite the international buyers and visitors.

In an effort to provide the visitors with an opportunity to see All about 3D Printing at one place, products lineup for this year will much vary. The show covers a vast range of products including 3D printers, 3D scanners, CAD/CAM software, printing material, platform service and luxury goods.

Keynote speakers include Terry Wohlers (Principal Consultant of Wohlers Associates, Inc.), Daniel Thomsen(General Manager of Stratasys Korea) and Seok Hwan You (CEO of Rokit). Breakout sessions will explore the frontier of 3D printing technology and its application in areas like manufacturing, luxury goods, medicine and art design. Panel discussion on the first day will cover The Future for 3D Printing in Asiaunder Terry Wohler’smoderation.

If you are interested in “all in one 3D Printing show, please visit http://www.inside3dprinting.com/seoul or contact Inside 3D Printing Secretariat at inside3dprinting@kintex.com .

Contacts:

Sophie Park
Phone Number: +82-31-995-8074/8078
Email:
cyp@kintex.com

Photo – http://photos.prnasia.com/prnh/20150423/8521502553

Source: KINTEX

Written by asiafreshnews

April 28, 2015 at 6:02 pm

Posted in Uncategorized

BOLT-68 Novelties

leave a comment »

PESEUX, Switzerland,  /PRNewswire/ — Launched at the Basel Fair 2014, BOLT-68 shortly became the major collection of BOMBERG with its patented bayonet system that turns your exclusive timepiece into a masculine pocket watch.

To view the Multimedia News Release, please click:

http://www.multivu.com/players/English/7499751-bolt-68-2015-novelties/

Object of desire, the BOLT-68 collection will further produce unconventional and audacious designs for new products launched in 2015.

(Photo: http://photos.prnewswire.com/prnh/20150427/739156 )

From the flashy colour of BOLT-68 NEON to the mad design of BOLT-68 SKULL BADASS, the collection will travel from Vegas to Macau with two timepieces inspired from the casino world, the BOLT-68 GAMBLER.

The BOLT-68 SAMURAI gives you a taste of Asia, and incorporates the elegance of the Japanese culture, whereas BOLT-68 FALCON transports us straight into the middle of an ardent desert.

All new BOLT-68 come with a medallion and a chain that have been sculpted as if they were a real piece of art.

ABOUT BOMBERG

BOMBERG is a newcomer to the World of Watches, first seeing the light of day in 2012 in Neuchatel, the cradle of the Swiss watchmaking industry. But don’t let this fool you; the brand has big ambitions and a clear message: BOMBERG is different.

“Creativity is the ability to think outside the box” according to Rick De La Croix, Chairman of BOMBERG. His vision is to create and establish a longstanding watch brand with international exposure – creating a new uncontested market space rather than competing in an existing one; a brand that doesn’t focus on its potential competitors, but rather on the needs and desires of its target community, capturing demand as it happens.

Swiss made, strong, distinguished and unconventional, the collections reinterpret and completely overturn classic watchmaking rules to create unusual timepieces. The brand’s intention confirms its ability to reinvent the image in this industry. Through its quality and the particular attention given to every detail, the collections BOLT-68 and 1968 take the wrist watch to a new level opening up new horizons for its trend-setting wearer.

Stephanie Fleury
International Marketing Director

BOMBERG
A division of Park Lane Partners SA
Rue de la Gare 4
2034 Peseux / NE
Switzerland
press@bomberg.ch
+41(32)557-57-91
http://www.bomberg.ch

Source: BOMBERG SA
Related Links:

Written by asiafreshnews

April 28, 2015 at 5:29 pm

Posted in Uncategorized

MecklerMedia’s Inside Bitcoins Conference in Hong Kong Announces Speakers for May 14-15, 2015

leave a comment »

NEW YORK /PRNewswire/ — MecklerMedia Corporation (OTCQX: MECK) announced the initial list of speakers for its Inside Bitcoins Conference and Expo, taking place at the Hong Kong Convention & Exhibition Centre on May 14-15, 2015.

Inside Bitcoins Hong Kong, now in its second year, already features 33 confirmed local and international speakers including keynote speaker Roger Ver, Bitcoin Evangelist / Angel Investor, and Founding Member and Board Advisor of the Bitcoin Foundation.

Garnering local support, Inside Bitcoins Hong Kong has partnered with the Bitcoin Association of Hong Kong.Leonhard Weese, President of the Bitcoin Association of Hong Kong will speak on a panel at Inside Bitcoins onMay 14 titled, “Hong Kong and Asia: Local Scene, Local Issues.”

“Inside Bitcoins Hong Kong brings together top industry leaders and developers to provide actionable insights across a diverse range of topics including the pros and cons of Bitcoin investing, the promise of Bitcoin 2.0 and decentralized technology, the shifting financial landscape in China, Bitcoin derivatives, regulation in Asia and beyond, alternative cryptocurrencies, running a Bitcoin exchange, Bitcoin for brick-and-mortar merchants, and creating the killer blockchain app,” says Stewart Quealy, Director of Content for MecklerMedia. “By attending Inside Bitcoins Hong Kong, attendees will gain exclusive access to the innovative people and businesses at the heart of the next wave of blockchain startups and FinTech companies.”

Additional confirmed speakers include:

  • Scott Bambacigno, Vice President, AlphaPoint
  • Samuel Bourque Co-Founder, CryptoLaw and NScrypt
  • Simon Dixon, CEO and Co-Founder, BankToTheFuture.com
  • Arthur Hayes, Co-Founder and CEO, BitMex (Bitcoin Mercantile Exchange)
  • Zennon Kapron, Mgmaanaging Director, Kapronasia
  • Evan Mo, Founder, BTC123.com/BTCBBS.com and CEO, https://digcoin.com/

Sponsors and exhibitors for the event include: Bitcoinnect; Bitmain; Genesis Mining; Verne Global; and LUXSTACK.

Prices increase on May 8, so register before to save with early bird pricing. For more information, and to register for Inside Bitcoins Hong Kong, visit InsideBitcoins.com/hong-kong.

If your company is interested in sponsoring or exhibiting at an upcoming Inside Bitcoins event, please contacteventsales@mecklermedia.com.

About MecklerMedia

MecklerMedia (OTCQX: MECK) is the leading producer of global trade shows, conferences, and digital publications covering 3D printing, robotics, and bitcoin/blockchain. MecklerMedia produces more than 25 conferences annually, including Inside 3D Printing, Inside Bitcoins, RoboUniverse, and the 3D Print Design Show. MecklerMedia’s news sites include Inside Bitcoins News and 3D Printing Industry, which provide up-to-date coverage to help drive business forward.

All current MecklerMedia press releases can be found online at: mecklermedia.com

For press inquiries, please contact press@mecklermedia.com.

Contact:

Christoph Rowen
Email:
christoph@mecklermedia.com

Source: MecklerMedia Corporation

Written by asiafreshnews

April 28, 2015 at 3:53 pm

Posted in Uncategorized

Novogen Posts Details on Rights Issue Offering for Shareholders

leave a comment »

SYDNEY /PRNewswire/ — US-Australian drug discovery company, Novogen Limited (NRT: ASX; NVGN: NASDAQ) (Company), announced last week that it lodged a prospectus with ASIC on 23 April 2015relating to its pro rata non-renounceable rights issue (Offering). The prospectus has been posted on its website and notices to shareholders and optionholders have been dispatched as required under the ASX Listing Rules. Copies of the notices to shareholders and optionholders are available on the Company’s website atwww.novogen.com.

This announcement intends to bring certain key matters and important dates to the attention of shareholders and to the market generally.

All dates and time in this announcement are to Sydney Australia date and time.

If you wish to buy shares which carry rights to participate in the Offering they must be bought on or before ASX closes tomorrow afternoon, 4pm on 28 April 2015.

This is because Wednesday 29th April 2015 is the “ex date” (the day on and from which any transfers of Novogen shares will not include rights to participate in the Offering).

Friday 1st May 2015 is the Record Date. Investors recorded as shareholders at 7pm on that day will qualify to participate in the Offering. If you are an optionholder wishing to participate in this Offering in respect of your options, you would need to exercise those options and pay (in cleared funds) for the resulting shares before this time.

The Offering is being made pursuant to a Prospectus dated and lodged with the Australian Securities & Investments Commission (ASIC) on 23 April 2015. The Prospectus has been lodged with ASX and is available from ASX’s website at www.asx.com.au under the code “NRT”. The Prospectus, copies of the notices posted to shareholders and optionholders in relation to the Offering, and a general information sheet can also be obtained from the Novogen website, www.novogen.com/prospectus. Neither ASIC nor ASX takes any responsibility for the contents of the Prospectus.

US investors

US residents should note that the Prospectus has not been registered with the SEC and therefore is only intended for Australian and New Zealand residents.

Certain US residents who are holders of ASX quoted shares and are also institutional “accredited investors” (as defined in Rule 501(a)(1), (2), (3), (7) and (8) under the U.S. Securities Act of 1933) may be eligible to take shares under this Offering.

The Offering is not open to investors who only hold the Company’s securities that trade on NASDAQ in the form of ADSs.

If a US entity believes it may be eligible, it should obtain professional advice or contact:

Dr Graham Kelly
Email:  graham.kelly@novogen.com
Phone:  +61 (0) 429 854 390

If a US investor is eligible, it should complete the US Investor Certificate (www.novogen.com/pdf/investor-certificate.pdf) and return it with their Entitlement and Acceptance Form and application money.

Graham Kelly, Novogen CEO and Executive Chairman, said, “This rights issue, in conjunction with the recent Placement, is intended to give the Company 2 years of funding to underpin its strong growth strategy.”

“A successful capital-raising at this time takes away the future uncertainties of the market at such a critical time in the Company’s development. With some years before we expect to be generating revenue, we have opted for certainty at a time of strong market sentiment for the Company specifically and the biotech sector generally.”

“By the start of 2015, just two short years after we had started, we had spent approximately $10 million developing two new drug technology platforms to the point where we had a good understanding of their potential and had identified 3 lead oncology drug candidates. That speed and that relatively low cost is testament to the capacity and dedication of this Company’s staff.”

“The Board believes that we now have a responsibility to our shareholders to maximise the opportunities on offer. We will only be taking steps we are confident of taking, but neither will your executive be risk-averse by looking for slow, organic growth. We believe that two exciting new drug technology platforms give us an extraordinary opportunity for growth. The task now is to grow into that opportunity.”

“Over the next 2 years, the Company needs an additional $60 million in funding to help bring drug candidates into the clinic for the identified opportunities of treatment of malignant ascites, malignant pleural effusion, malignant melanoma, castrate-resistant prostate cancer, glioblastoma, medulloblastoma, diffuse intrinsic pontine glioma, neuroblastoma, brain damage, SanFilippo Syndrome and muscular dystrophies. Our objective with this current capital-raise is to ensure that we will be in or close to being in the clinic for as many of these indications as it believes it reasonably can within the next 2 years without worrying about funding,” Kelly said.

The securities offered pursuant to the Prospectus will only be issued on the basis of the Entitlement and Acceptance Form accompanying the Prospectus that is scheduled for despatch to eligible shareholders on 6 May 2015 and only after the expiry of the exposure period contemplated by section 727(3) of the Corporations Act 2001 (Cth).

Any person who wishes to apply for securities under this Offering will need to complete an Entitlement and Acceptance accompanying the Prospectus. No Entitlement and Acceptance Form will be accessible electronically.

All interested applicants should read the Prospectus in its entirety before deciding whether to acquire securities under this Offering.

About Novogen

Novogen is a public, Australian-US drug-development company whose shares trade on both the Australian Securities Exchange (‘NRT’) and NASDAQ (‘NVGN’). The Novogen group includes US-based, CanTx Inc, a joint venture company with Yale University. Novogen has two main drug technology platforms: super-benzopyrans (SBPs) and anti-tropomyosins (ATMs). SBP compounds have been designed to kill the full heterogeneity of cells within a tumor, but with particular activity against the slowly-dividing, less differentiated cancer stem (tumor-initiating) cell. The ATM compounds target the micro-filament component of the cancer cell’s cytoskeleton and have been designed to combine with anti-microtubule drugs (taxanes, vinca alkaloids) to produce comprehensive and fatal destruction of the cancer cell cytoskeleton. The Company pipeline currently comprises two SBP drug candidates (TRXE-002, TRXE-009) and one ATM drug candidate (Anisina).

For more information, please visit www.novogen.com

Corporate Contact

Dr. Graham Kelly

Executive Chairman & CEO

Novogen Group

Graham.Kelly@novogen.com 

+61 (0) 2 9472 4100

Media Enquiries

Cristyn Humphreys

Chief Operating Officer

Novogen Group

Cristyn.Humphreys@novogen.com

+61 (0) 2 9472 4111

Forward Looking Statement

All statements other than statements of historical fact included in this announcement including, without limitation, statements regarding future plans and objectives of Novogen Limited (“Novogen”) are forward-looking statements. When used in this announcement, forward-looking statements can be identified by words such as ‘may’, ‘could’, ‘should’, ‘would’, ‘believes’, ‘estimates’, ‘targets’, ‘expects’ or ‘intends’ and other similar words that involve risks and uncertainties.

Such statements relate to future events and expectations and as such involve known and unknown risks and uncertainties. These risks and uncertainties include, among other things, market conditions, weather risks, economic and political risks.

These statements are based on an assessment of present economic and operating conditions, and on a number of assumptions regarding future events and actions that, as at the date of this announcement, are expected to take place. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties, assumptions and other important factors, many of which are beyond the control of Novogen, its directors and management, which could cause Novogen’s actual results to differ materially from the results expressed or anticipated in these statements.

Novogen cannot and does not give any assurance that the results, performance or achievements expressed or implied by the forward-looking statements contained in this announcement will actually occur and investors are cautioned not to place undue reliance on these forward-looking statements. Actual results, actions, and developments may differ materially from those expressed or implied by those forward-looking statements depending on a variety of factors.

Novogen does not undertake to update or revise forward-looking statements, or to publish prospective financial information in the future, regardless of whether new information, future events or any other factors affect the information contained in this announcement, except where required by applicable law and stock exchange listing requirements.

Source: Novogen Ltd
Related Links:

Written by asiafreshnews

April 28, 2015 at 12:13 pm

Posted in Uncategorized

Institutional and political crises of Brazil and Latin American integration heat up debates at COMANDATUBA FORUM

leave a comment »

SAO PAULO, April 23, 2015 /PRNewswire/ — Last Sunday, April 19, the 14th FORUM DE COMANDATUBA [Comandatuba Forum] took place, organized by LIDE – Grupo de Lideres Empresariais [Group of Business Leaders]. At the 2015 gathering, the 700 participants debated The role of leaders in economic and social development in Latin America, and Measures to combat the institutional and political crisis in Brazil.

Former President Fernando Henrique Cardoso (FHC) stated in his talk that “we want more and not less democracy; more integration and more freedom to live better.” Colombian former President, Alvaro Uribe, who was unable to attend the Forum, said in a message that Latin America has a number of opportunities and faces great challenges, and that Brazil has a lot of potential to overcome them.

Jorge Quiroga, former President of Bolivia, stated that we must confront the challenges involved in regional integration, and Brazil has a central role to play. For Vicente Fox, former President of Mexico, two pillars are essential to the exercise of democracy: purpose and performance. In the evaluation of Luis Alberto Lacalle, former President of Uruguay, governing is not finding easy solutions.

“Debate, a diversity of opinions, a search for solutions and a positive agenda can help us to find ways out of the difficulties Brazil is going through,” said Joao Doria Jr., President of LIDE.

Eduardo Cunha, President of Brazil’s Chamber of Deputies, noted that 1% of GDP was lost as a consequence of the Petrobras scandal. “Corruption is devastating; it corrodes and paralyzes the economy. But of one thing we can be sure: corruption will not enjoy impunity, there isn’t the slightest possibility of that.”

The Forum featured the involvement of major brands: sponsorship by AMIL and support by GOCIL. Special participation by ACCENTURE, ATHIE WOHNRATH, BANCO ALFA, BASF, CINE, NATURA, REDE RECORD, SOUZA CRUZ and SAMSUNG, with participation by 3M, AVIS, BMW, JBS and PPG. The event had the collaboration of AMERICAN EXPRESS, AIR LIQUIDE, AVENTURA ENTRETENIMENTO, BANCO ITAU, BODYTECH, CBF, EMS, GRUPO MARTINS, ODONTOPREV, PENALTY, PEPSICO, MARINGA, TAKEDA, TETRA PAK, VALE PRESENTE, WHIRLPOOL and ZURICH. Official suppliers were AGAXTUR REGENT, CDN, CHANDON, COOXUPE, ECCAPLAN, FORMAG’S, GRUPO COMPANHIA, GRUPO PETROPOLIS, KELLOG´S, MISTRAL, PEPSICO and VINCI, RODOBENS COMUNICATION EMPRESARIAL and UPS. EDITORA TRES, ESTADAO, radio stations BAND AM, BAND NEWS FM and JOVEM PAN, the newspaper PROPAGANDA & MARKETING, the magazine FORUM & NEGOCIOS, PR NEWSWIRE, TV CULTURA, TV LIDE and VB COMUNICACAO are media partners. 3M, CASA LEAO, DOLCE & GABBANA, NIELSEN, PPG, SILVIA FURMANOVICH, TAKEDA and SAMSUNG had exclusive spaces at the VILLA FORUM.

Contact:
Fernanda Spagnuolo
Phone: (55-11) 3039-6067/e-mail: fernandaspagnuolo@grupodoria.com.br
Source: FÓRUM DE COMANDATUBA

Written by asiafreshnews

April 28, 2015 at 10:04 am

Posted in Uncategorized

Backbone Solutions AG Launches virtual-server.net

leave a comment »

SCHINDELLEGI, Switzerland, April 23, 2015 /PRNewswire/ — The Swiss internet service provider Backbone Solutions AG has launched virtual-server.net, a platform for powerful yet low-priced virtual servers. These servers are easy to operate and provide a large range of applications at low prices; they are particularly suitable for small and medium-sized companies or for private persons who are well aware of their requirements for server capacity and performance.

(Photo: http://photos.prnewswire.com/prnh/20150423/740398)

Multi-functional like a Swiss army knife
Michael Vontobel, CEO and company founder, presented the new product: “In line with our motto of “keeping it simple”, we offer low-priced virtual servers that are easy to operate and suitable for day-to-day use”.

http://www.virtual-server.net/ offers Infrastructure as a Service (IaaS). The servers are versatile in their application. Some examples of their use would be for online shopping, file, web or backup servers, test environments and VPN tunnels.

Set up in only two steps
“Our product is distinguished by its ease of operation”, explained Marcel Gmur, COO of Backbone Solutions AG. A virtual-server.net can be set up in two simple steps: first the customer chooses the desired server size from among three predefined offers for Windows or Linux, then he chooses the OS template he requires. All major distributions such as CentOS, Debian, Fedora, Red Hat, openSUSE, Ubuntu and the Windows versions 7, 8.1, 2008 or 2012 are available. Their number is continuously increasing.

Safe, speedy and 100% Swiss quality
The servers are 100% operated at Swiss datacentres. Moreover, several firewalls and optional AES encryption provide the highest security levels. Thanks to the latest SSD technology and direct links to all networks worldwide, both high speed and high availability can be guaranteed. The only thing not typically Swiss is the price: the servers are available from as little as € 11.00 / month – a lot of performance for little money!

About virtual-server.net
virtual-server.net is a product by Backbone Solutions AG. The company was founded in 1998 and offers professional, high-quality solutions for Infrastructure as a Service, VoIP telephony and connectivity. Over 40,000 national and international customers have already opted for a solution by Backbone Solutions AG. The company operates its own, comprehensive IT infrastructure in high-security datacentres in Switzerland, thus guaranteeing the highest security levels, maximum data protection and top quality.

Contact
virtual-server.net by Backbone Solutions AG, Marcel Gmur
Chaltenbodenstrasse 4b; CH-8834 Schindellegi
Tel. +41-44-276-19-19; info@virtual-server.net; http://www.virtual-server.net/
Source: SecureRack

Written by asiafreshnews

April 28, 2015 at 9:12 am

Posted in Uncategorized